Globally, stroke accounts for the second most common cause of mortality and the third most common cause of disability. In India, data regarding the prevalence of stroke is lacking, however, the crude prevalence rate of stroke in India was 147/100,000 and the annual incidence rate was 36/100,000 in 2001. 1 It is well-established that intravenous thrombolytic therapy plays a pivotal role in the management of acute ischemic stroke and faster administration of intravenous tissue plasminogen activator is associated with better short-term outcomes in clinical practice. 2 Chugh C, Indian Society of Critical Care Medicine, 2019 Jun;23(Suppl 2):S140. Muth CC, Jama, 2020 Jun 2;323(21):2184-5.
In this regard, Dr. Reddy Laboratories has organized an interactive Webinar on 27 th August 2020 at 6 PM. In this webinar, Dr. Arul Selvan, Senior Consultant Neurologist, will discuss “Thrombolysis In Acute…
